Anja Reuter on Muck Rack

Anja Reuter

Verified
Gaggenau
As seen in: Rundschau für den Lebensmittelhandel, El País, MDPI, The Lancet, Daily Maverick, Health-e
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anja

Contact Anja, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis

|
By Anja Reuter Verified, Jennifer Furin
| MDPI
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Anja Reuter 1 and Jennifer Furin 2,* 1 The Sentinel Project on Pediatric Drug-Resistant Tuberculosis, Cape Town 7405, South Africa 2 Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, USA * Author to whom correspondence should be addressed.
Open in Who Shared Issue with article?

Celebrating choice in the care of people living with drug-resistant tuberculosis

|
By Anja Reuter Verified, Cape Town, Jennifer Furin
| The Lancet Verified
9-month treatment with oral delamanid, linezolid, levofloxacin, and pyrazinamide could represent a new treatment option for participants with fluoroquinolone-sensitive multidrug-resistant tuberculosis.
Open in Who Shared Issue with article?

Household contact management for rifampicin-resistant tuberculosis

|
By Anja Reuter Verified, Ivy Apolisi, Médecins Sans Frontiàres
| The Lancet Verified
The Article by Peter Dodd and colleagues (July, 2022) 1 Dodd PJ Mafirakureva N Seddon JA McQuaid CF The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study. provides a rationale for why we should increase the global use of household contact management for people exposed to rifampicin-resistant tuberculosis.
Open in Who Shared Issue with article?
See all 16 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified